Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...
The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...
The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback